Top

Published in:

01-12-2020 | Brain Death | Update

Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study)

Authors: Natalia Elis Giordani, Caroline Cabral Robinson, Glauco Adrieno Westphal, Regis Goulart Rosa, Daniel Sganzerla, Alexandre Biasi Cavalcanti, Flávia Ribeiro Machado, Luciano Cesar Pontes Azevedo, Fernando Augusto Bozza, Cassiano Teixeira, Joel de Andrade, Cristiano Augusto Franke, Cátia Moreira Guterres, Itiana Cardoso Madalena, Adriane Isabel Rohden, Sabrina Souza da Silva, Luiza Vitelo Andrighetto, Gabriela Soares Rech, Bruna dos Passos Gimenes, Luciano Serpa Hammes, Daniela Ferreira Salomão Pontes, Maureen O. Meade, Maicon Falavigna

Published in: Trials | Issue 1/2020

Abstract

Background

The quality of clinical care of brain-dead potential organ donors may help reduce donor losses caused by irreversible or unreversed cardiac arrest and increase the number of organs donated. We sought to determine whether an evidence-based, goal-directed checklist for donor management in intensive care units (ICUs) can reduce donor losses to cardiac arrest.

Methods/design

The DONORS study is a multicentre, cluster-randomised controlled trial with a 1:1 allocation ratio designed to compare an intervention group (goal-directed checklist for brain-dead potential organ donor management) with a control group (standard ICU care). The primary outcome is loss of potential donors due to cardiac arrest. Secondary outcomes are the number of actual organ donors and the number of solid organs recovered per actual donor. Exploratory outcomes include the achievement of relevant clinical goals during the management of brain-dead potential organ donors. The present statistical analysis plan (SAP) describes all primary statistical procedures that will be used to evaluate the results and perform exploratory and sensitivity analyses of the trial.

Discussion

The SAP of the DONORS study aims to describe its analytic procedures, enhancing the transparency of the study. At the moment of SAP subsmission, 63 institutions have been randomised and were enrolling study participants. Thus, the analyses reported herein have been defined before the end of the study recruitment and database locking.

Trial registration

ClinicalTrials.gov, NCT03179020. Registered on 7 June 2017.

Available only for authorised users

DuBose J, Salim A. Aggressive organ donor management protocol. J Intensive Care Med. 2008;23:367–75. https://doi.org/10.1177/0885066608324208.CrossRefPubMed

Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304:2620–7. https://doi.org/10.1001/jama.2010.1796.CrossRefPubMed

Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Chutchfield M, et al. Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med. 2015;373:405–14. https://doi.org/10.1056/NEJMoa1501969.CrossRefPubMed

Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491–9. https://doi.org/10.1056/NEJMsa0810119.CrossRefPubMed

Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–32. https://doi.org/10.1056/NEJMoa061115.CrossRefPubMed

Weiss CH, Moazed F, McEvoy CA, Singer BD, Szleifer I, Amaral LA, et al. Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study. Am J Respir Crit Care Med. 2011;184:680–6. https://doi.org/10.1164/rccm.201101-0037OC.CrossRefPubMedPubMedCentral

Cavalcanti AB, Bozza FA, Machado FR, Salluh JI, Campagnucci VP, Vendramim P, et al. Effect of a quality improvement intervention with daily round checklists, goal setting, and clinician prompting on mortality of critically ill patients: a randomized clinical trial. JAMA. 2016;315:1480–90. https://doi.org/10.1001/jama.2016.3463.CrossRefPubMed

Bion J, Richardson A, Hibbert P, Beer J, Abrusci T, McCutcheon M, et al. ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Saf. 2013;22:110–23. https://doi.org/10.1136/bmjqs-2012-001325.CrossRefPubMed

Ko HC, Turner TJ, Finnigan MA. Systematic review of safety checklists for use by medical care teams in acute hospital settings – limited evidence of effectiveness. BMC Health Serv Res. 2011;11:211. https://doi.org/10.1186/1472-6963-11-211.CrossRefPubMedPubMedCentral

10.

Westphal GA, Zaclikevis VR, Vieira KD, Cordeiro Rde B, Horner MB, Oliveira TP, et al. A managed protocol for treatment of deceased potential donors reduces the incidence of cardiac arrest before organ explant. Rev Bras Ter Intensiva. 2012;24:334–40. https://doi.org/10.1590/S0103-507X2012000400007.CrossRefPubMedPubMedCentral

11.

Westphal GA, Coll E, de Souza RL, Wagner S, Montemezzo A, Cani de Souza FC, et al. Positive impact of a clinical goal-directed protocol on reducing cardiac arrests during potential brain-dead donor maintenance. Crit Care. 2016;20:323. https://doi.org/10.1186/s13054-016-1484-1.CrossRefPubMedPubMedCentral

12.

Helms AK, Torbey MT, Hacein-Bey L, Chyba C, Varelas PN. Standardized protocols increase organ and tissue donation rates in the neurocritical care unit. Neurology. 2004;63:1955–7. https://doi.org/10.1212/01.WNL.0000144197.06562.24.CrossRefPubMed

13.

Franklin GA, Santos AP, Smith JW, Galbraith S, Harbrecht BG, Garrison RN. Optimization of donor management goals yields increased organ use. Am Surg. 2010;76:587–94.PubMed

14.

Malinoski DJ, Daly MC, Patel MS, Oley-Graybill C, Foster CE 3rd, Salim A. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. J Trauma. 2011;71:990–6. https://doi.org/10.1097/TA.0b013e31822779e5.CrossRefPubMed

15.

Salim A, Velmahos GC, Brown C, Belzberg H, Demetriades D. Aggressive organ donor management significantly increases the number of organs available for transplantation. J Trauma. 2005;58:991–4. https://doi.org/10.1097/01.TA.0000168708.78049.32.CrossRefPubMed

16.

Malinoski DJ, Patel MS, Daly MC, Oley-Graybill C, Salim A, UNOS Region 5 DMG workgroup. The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med. 2012;40:2773–80. https://doi.org/10.1097/CCM.0b013e31825b252a.CrossRefPubMed

17.

Patel MS, Zatarain J, De La Cruz S, Sally MB, Ewing T, Crutchfield M, et al. The impact of meeting donor management goals on the number of organs transplanted per expanded criteria donor: a prospective study from the UNOS Region 5 Donor Management Goals Workgroup. JAMA Surg. 2014;149:969–75. https://doi.org/10.1001/jamasurg.2014.967.CrossRefPubMed

18.

Westphal GA, Robinson CR, Biasi A, Machado FR, Rosa RG, Teixeira C, et al. DONORS (Donation Network to Optimise Organ Recovery Study): study protocol to evaluate the implementation of an evidence-based checklist for brain-dead potential organ donors management in intensive care units, a cluster randomized trial. BMJ Open. 2019;9:e028570. https://doi.org/10.1136/bmjopen-2018-028570.CrossRefPubMedPubMedCentral

19.

Caille A, Kerry S, Tavernier E, Leyrat C, Eldridge S, Giraudeau B, et al. Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. BMJ. 2016;354:i4291.CrossRef

20.

R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. https://www.R-project.org/. Accessed 29 Jul 2019.

21.

Pandharipande PP, Shitani AK, Hagerman HE, St Jacques PJ, Rice TW, Sanders NW, et al. Derivation and validation of Spo₂/Fio₂ ratio to impute for Pao₂/Fio₂ ratio in the respiratory component of the Sequential Organ Failure Assessment score. Crit Care Med. 2009;37(4):1317–21. https://doi.org/10.1097/CCM.0b013e31819cefa9.CrossRefPubMedPubMedCentral

22.

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Failure Assessment) score to describe organ disfunction/failure. Intensive Care Med. 1996;22:707–10.CrossRef

23.

Campbell MK, Piaggio G, Elbourne DR, Altman DG, CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661. https://doi.org/10.1136/bmj.e5661.CrossRefPubMed

24.

Collet D. Modelling survival data in medical research. 2nd ed. Boca Raton: Chapman and Hall/CRC; 2003.

25.

Twisk JWR. Applied longitudinal data analysis for epidemiology: a practical guide. New York: Cambridge University Press; 2003.

26.

Pedroza C, Thanh Trong VT. Performance of models for estimating absolute risk difference in multicenter trials with binary outcome. BMC Med Res Methodol. 2016;16:113. https://doi.org/10.1186/s12874-016-0217-0.CrossRefPubMedPubMedCentral

27.

Leyrat C, et al. Cluster randomized trials with a small number of clusters: which analyses should be used? Int J Epidemiol. 2018;47(1):321–31. https://doi.org/10.1093/ije/dyx169.

28.

Pedroza C, Truong VTT. Estimating relative risks in multicenter studies with a small number of centers — which methods to use? A simulation study. Trials. 2017;18:512. https://doi.org/10.1186/s13063-017-2248-1.CrossRefPubMedPubMedCentral

Title: Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study)
Authors: Natalia Elis Giordani
Caroline Cabral Robinson
Glauco Adrieno Westphal
Regis Goulart Rosa
Daniel Sganzerla
Alexandre Biasi Cavalcanti
Flávia Ribeiro Machado
Luciano Cesar Pontes Azevedo
Fernando Augusto Bozza
Cassiano Teixeira
Joel de Andrade
Cristiano Augusto Franke
Cátia Moreira Guterres
Itiana Cardoso Madalena
Adriane Isabel Rohden
Sabrina Souza da Silva
Luiza Vitelo Andrighetto
Gabriela Soares Rech
Bruna dos Passos Gimenes
Luciano Serpa Hammes
Daniela Ferreira Salomão Pontes
Maureen O. Meade
Maicon Falavigna
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Brain Death
Care
Published in: Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-020-04457-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study)

Abstract

Background

Methods/design

Discussion

Trial registration

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods/design

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2020

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

Effect of nutritional interventions on discharged older patients: study protocol for a randomized controlled trial

Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial

Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial

Short-term fasting accompanying chemotherapy as a supportive therapy in gynecological cancer: protocol for a multicenter randomized controlled clinical trial